Adenike O. Adekeye, David Needham, & Ruman Rahman. (2023). Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic Delivery. MDPI AG.
Chicago Style (17th ed.) CitationAdenike O. Adekeye, David Needham, and Ruman Rahman. Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic Delivery. MDPI AG, 2023.
MLA (9th ed.) CitationAdenike O. Adekeye, et al. Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic Delivery. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.